Summit Financial LLC Takes $207,000 Position in AstraZeneca PLC (NASDAQ:AZN) : vimarsana.com

Summit Financial LLC acquired a new position in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 3,078 shares of the company’s stock, valued at approximately $207,000. Several other institutional investors have also added to or […]

Related Keywords

, Astrazeneca Company Profile , Astrazeneca , Bryn Mawr Capital Management , Clearstead Advisors , Deutsche Bank Aktiengesellschaft , Summit Financial , Morgan Stanley , Gradient Investments , Securities Exchange Commission , Wealth Management , Free Report , Mawr Capital Management , Glenview Trust , Get Free Report , Bank Aktiengesellschaft , Visit Holdingschannel , Astrazeneca Daily , Nasdaq Azn , Azn , Medical , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,